Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 110 record(s)

Req # A-2020-000364

Adverse Drug Reaction (ADR) for TERIFLUNOMIDE. Report number: E2B_02791526.

Organization: Health Canada

12 page(s)
March 2021

Req # A-2020-000592

Adverse Drug Reaction (ADR) for Botulinum toxin type A. Report number: E2B_03136030.

Organization: Health Canada

8 page(s)
March 2021

Req # A-2020-000889

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-110509-318, Laboratories Canada Overview.

Organization: Health Canada

17 page(s)
March 2021

Req # A-2020-000993

Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_01354481, E2B_02405078.

Organization: Health Canada

58 page(s)
March 2021

Req # A-2020-001075

Adverse Reaction Reports (AERs). Report numbers: E2B_03257835, E2B_03257836, E2B_03259803.

Organization: Health Canada

54 page(s)
March 2021

Req # A-2020-001329

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-113071-262, Procedures for Addressing Allegations of Breach of Scientific Integrity.

Organization: Health Canada

24 page(s)
March 2021

Req # A-2020-001371

Adverse Reaction Reports (AERs) for LEUPROLIDE ACETATE. Report numbers: E2B_03023786, E2B_03023776.

Organization: Health Canada

16 page(s)
March 2021

Req # A-2020-001554

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-075533-873, Meeting with Social Sciences and Humanities Research Council.

Organization: Health Canada

29 page(s)
March 2021

Req # A-2020-001597

Adverse Drug Reaction (ADR). Report number: E2B_03352370.

Organization: Health Canada

7 page(s)
March 2021

Req # A-2020-001606

Adverse Drug Reaction (ADR). Report number: E2B_03343270.

Organization: Health Canada

7 page(s)
March 2021
Date modified: